Company intelligence
Innovation Network
We Gather to anticipate and shape the future of human-centered clinical trial services and technologies.
About Innovation Network
Gather people in order to anticipate and shape the future of human-centered clinical trial services and technologies We are all more aware of the need for human-centric clinical research. Call it patient-centric or participant-centric – the human is at the center. The sector is changing, and we need digitally competent trials to keep up with that change. We can bring people together and amplify thought leaders to anticipate and shape the future of human centered clinical research services and technology.
Verified activity
Signals from Innovation Network
6 published signals
Partnerships
Innovation Network welcomed Medidata Solutions, a Dassault Systèmes brand, as a partner of the emergING 2026 clinical research event.
Reported by Innovation Network
Presence & Recognition
Innovation Network is hosting the Investigator Meetings: Did We All Fly Here to Watch Slides? Dive Team gathering in West Chester, Pennsylvania from October 5 to 8, 2026, to discuss how to reimagine investigator meetings.
Reported by Innovation Network
Presence & Recognition
Innovation Network is attending the RTP NC event on September 10th for lunch and a discussion with Weave Bio's Tim Spaeder and Chelsey Kennedy on AI changing regulatory work across drug development.
Reported by Basia Coulter, Ph.D., M.Sc.
Partnerships
Innovation Network welcomed the Association of Multisite Research Corporations (AMRC) as a partner of the Gathering in October.
Reported by Innovation Network
Presence & Recognition
Innovation Network announced that Dive Team The Patient Journey, Reimagined: Where Can Technology and AI Transform Clinical Trial Engagement will be exhibiting at the Emerging2026 Clinical Research Patient Engagement Activity in West Chester, Pennsylvania from October 5 to 8.
Reported by Innovation Network
Products & Services
Innovation Network congratulated Weave Bio for making it possible to achieve a 100-to-3-hour reduction in time to the first draft of a regulatory submission.
Reported by Basia Coulter, Ph.D., M.Sc.